Related Experiment Video
Updated: Apr 4, 2026

08:05
Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
Published on: June 10, 2025
1.4K
Generative Artificial Intelligence for Medical Summarization in Prostate Cancer: Comparative Evaluation by Physicians
Charles Raynaud1, Loris Dematini2, Jean-Emmanuel Bibault1,2
1Radiation Oncology Department, Hôpital Européen Georges Pompidou, Paris, France.
JCO Clinical Cancer Informatics
|April 2, 2026
Summary
Physicians preferred the Consensus language model for summarizing prostate cancer abstracts, while patients favored Gemma 2B. This highlights the need to choose AI models carefully for specific oncology communication needs.
Area of Science:
- Artificial Intelligence in Medicine
- Oncology Research
- Clinical Communication
Background:
- The rapid increase in scientific publications poses challenges for accessing up-to-date medical information.
- Language models (LMs) show promise for scientific content generation and summarization.
- LM performance in oncology needs evaluation from both professional and patient viewpoints.
Purpose of the Study:
- To evaluate the performance of four language models (Llama 3, Mistral Large 2, Gemma 2B, Consensus) in summarizing and translating prostate cancer abstracts.
- To assess the perceived quality of LM-generated summaries from physician and patient perspectives.
Main Methods:
- A prospective, survey-based pilot study was conducted.
- Four LMs summarized seven prostate cancer abstracts.
- Physicians and patients evaluated summaries based on accuracy, usefulness, organization, and comprehensibility using Likert scales.
Main Results:
- Physicians favored Consensus for completeness, accuracy, currency, organization, and usefulness.
- Patients rated Gemma 2B highest for conciseness and comprehensibility, and Consensus for organization.
- Llama 3 and Mistral Large 2 showed good overall performance but fewer strong positive ratings.
Conclusions:
- Perceived quality of LM summaries varied significantly between models and user groups (physicians vs. patients).
- Consensus was preferred by physicians, while Gemma 2B was favored by patients.
- Model selection for generative AI in oncology should align with specific clinical communication goals.
Related Concept Videos
Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Cancer Survival Analysis
838
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
838

